Compound Details
TURINOVA tablets contain Chlorodehydromethyltestosterone (CAS 2446-23-3). Pharmaceutical-grade anabolic support by NovaTech Sciences for strength, performance, and muscle growth.
Form
Oral tablets
Strength
10 mg Chlorodehydromethyltestosterone per tablet
Packaging
Bottle of 50 tablets
Tablet Type
Pharmaceutical-grade anabolic steroid
Usage Category
Muscle recovery, strength enhancement, endurance, therapeutic anabolic support
Suitable For
Athletes, bodybuilders, and individuals on structured anabolic recovery cycles
TURINOVA Tablets by NovaTech Sciences contain premium-grade Chlorodehydromethyltestosterone (CAS 2446-23-3), an orally active anabolic compound widely recognized for its association with strength support, athletic performance environments, and lean muscle maintenance. Chlorodehydromethyltestosterone is globally identified through CAS 2446-23-3, ensuring chemical authenticity, traceability, and pharmaceutical-grade standardization across international markets.
NovaTech Sciences manufactures Chlorodehydromethyltestosterone CAS 2446-23-3 using strict quality control protocols designed to ensure compound purity, formulation stability, and global export compliance.
Chlorodehydromethyltestosterone, commonly known as Turinabol, is an orally active anabolic compound derived from testosterone. Registered under CAS 2446-23-3, it is characterized by structural modifications that influence its anabolic properties and metabolic stability.
The CAS registry number 2446-23-3 serves as the internationally recognized chemical identifier for Chlorodehydromethyltestosterone. This identifier ensures accurate compound verification and supports regulatory transparency within pharmaceutical supply chains.
Chlorodehydromethyltestosterone (CAS 2446-23-3) interacts with androgen receptors in muscle tissue, supporting biological pathways related to protein synthesis and nitrogen retention. These processes are associated with muscle maintenance, physical strength development, and performance-related physiological environments.
Unlike certain androgenic compounds, Chlorodehydromethyltestosterone CAS 2446-23-3 is known for minimal aromatization, meaning it does not significantly convert to estrogen. This characteristic has contributed to its reputation for promoting lean muscle development without excessive water retention.
Each production batch of Chlorodehydromethyltestosterone CAS 2446-23-3 undergoes rigorous testing to confirm compound purity, identity verification, and dosage accuracy.
NovaTech Sciences operates as a trusted manufacturer, supplier, and exporter of pharmaceutical-grade anabolic compounds for international markets. By clearly specifying CAS 2446-23-3, TURINOVA tablets maintain regulatory transparency and compound authenticity.
These quality standards ensure that Chlorodehydromethyltestosterone tablets meet professional pharmaceutical distribution requirements.
NovaTech Sciences focuses on pharmaceutical precision, global regulatory compliance, and compound quality assurance. TURINOVA tablets containing Chlorodehydromethyltestosterone CAS 2446-23-3 are produced using advanced manufacturing technologies designed to maintain product stability and reliability.
For distributors and pharmaceutical buyers seeking a reliable source of Chlorodehydromethyltestosterone (CAS 2446-23-3), TURINOVA Tablets by NovaTech Sciences provide verified compound identity, pharmaceutical manufacturing standards, and global supply reliability. With rigorous quality control systems and CAS-verified authenticity, Chlorodehydromethyltestosterone CAS 2446-23-3 remains a recognized compound associated with strength support, performance environments, and lean muscle maintenance.
Precautions
Contraindications
Chlorodehydromethyltestosterone is a synthetic anabolic-androgenic steroid identified by CAS Number 2446-23-3. It is also known as Dehydrochloromethyltestosterone, 4-Chloromethandienone and Oral Turinabol. The compound has the molecular formula C₂₀H₂₇ClO₂ and a molecular weight of approximately 334.9 g/mol.
Nova Techsciences associates Chlorodehydromethyltestosterone with its TURINOVA tablet formulation. The current compound page lists a strength of 10 mg per tablet and a bottle containing 50 tablets. These details should remain consistent across the compound page, product page, packaging, structured data and batch documentation.
The CAS number provides a standard chemical identifier that distinguishes Chlorodehydromethyltestosterone from Methandienone, Fluoxymesterone, Oxandrolone and other steroidal compounds with different structures and safety profiles.
Chlorodehydromethyltestosterone is structurally related to testosterone and Methandienone but includes chemical modifications that give it a separate identity. A responsible compound page should avoid unsupported therapeutic or performance claims and instead focus on verified chemistry, analytical testing and regulatory status.
Suitable supporting documentation may include raw-material identification, active-compound assay, impurity analysis, reference-standard comparison, stability testing and batch-specific Certificates of Analysis.
Each batch should have a unique identification number linked to its manufacturing and laboratory-release records. Claims concerning purity, pharmaceutical grade or manufacturing compliance should only be published when supported by current documentation.
Chlorodehydromethyltestosterone is not a general health supplement. Anabolic-androgenic steroids can affect liver function, cardiovascular health, cholesterol, hormonal balance, fertility and psychological wellbeing.
The compound should not be presented for self-medication, bodybuilding, athletic enhancement or use by minors. It is included within the anabolic-agent category of the 2026 World Anti-Doping Agency Prohibited List, which took effect on January 1, 2026.
For audiences in the Netherlands, United Kingdom and other European markets, Nova Techsciences should clearly communicate the compound’s marketing-authorisation status, legal supply category, responsible organisation and adverse-event reporting process.
Levothyroxine Sodium T4 is a synthetic thyroid hormone identified by CAS Number 55-03-8. Nova Techsciences presents it as a 50 mcg tablet. Thyroid medicines require precise strength control, professional monitoring and clear warnings against unsupervised weight-loss or metabolic use.
Cabergoline is a dopamine D2 receptor agonist identified by CAS Number 81409-90-7. Nova Techsciences lists it as a 0.5 mg tablet. It is pharmacologically different from anabolic steroids and requires separate cardiovascular precautions, interaction information and professional clinical monitoring.
Fluoxymesterone is an oral anabolic-androgenic compound identified by CAS Number 76-43-7. Nova Techsciences presents it as a 5 mg tablet. Its compound information should independently address liver, cardiovascular, hormonal and reproductive risks alongside batch traceability and regulatory status.
Liothyronine Sodium T3 is an active synthetic thyroid hormone identified by CAS Number 55-06-1. It requires precise formulation, thyroid-function monitoring and professional medical oversight. It should not be presented for unsupervised metabolism, fat-loss or sporting-performance purposes.
Oxandrolone is an anabolic-androgenic steroid identified by CAS Number 53-39-4. It has a distinct chemical and safety profile from Chlorodehydromethyltestosterone. Its compound page should focus on verified identity, regulatory status, liver and cardiovascular precautions and transparent batch documentation.
Chlorodehydromethyltestosterone should ultimately be presented through accurate chemical identification, transparent quality records, balanced risk communication and clearly stated regulatory limitations.
Premium aromatase inhibitor tablets for estrogen suppression and effective hormone balance support.
Buy Tamoxifen Citrate (CAS 54965-24-1) by NovaTech Sciences. Premium tablets for estrogen modulation, hormone support, and targeted receptor activity.
Buy Anastrozole (CAS 120511-73-1) by NovaTech Sciences. Pharmaceutical-grade aromatase inhibitor tablets for estrogen suppression and hormone regulation.
